Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 21

Results For "IMI"

5317 News Found

SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026
Digitisation | June 24, 2026

SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026

Bengaluru-based startup recognised for building autonomous AI agents for pharmaceutical and medtech commercial operations, joins select cohort of 40 startups in India-focused accelerator programme


CARE Hospitals completes 500 robotic knee replacement surgeries in one year
Hospitals | June 24, 2026

CARE Hospitals completes 500 robotic knee replacement surgeries in one year

Visakhapatnam-based hospital reaches major milestone in robotic orthopaedics, helping patients across North Andhra Pradesh and Odisha regain mobility through precision-assisted knee replacement procedures.


AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients


Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
Biopharma | June 23, 2026

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making


KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
Hospitals | June 23, 2026

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,


Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
Drug Approval | June 23, 2026

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

The filing is backed by positive Phase 3 results recently published in JAMA Neurology


FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
News | June 23, 2026

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average


Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
News | June 23, 2026

Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results

The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines


WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
News | June 23, 2026

WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center

Clearing 19 biologics for Europe market


HCG launches breast Cancer Care Clinic in Bengaluru
Healthcare | June 23, 2026

HCG launches breast Cancer Care Clinic in Bengaluru

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted